Perspective - (2025) Volume 17, Issue 1
Received: 01-Feb-2025, Manuscript No. jbabm-25-168525;
Editor assigned: 03-Feb-2025, Pre QC No. P-168525;
Reviewed: 17-Feb-2025, QC No. Q-168525;
Revised: 22-Feb-2025, Manuscript No. R-168525;
Published:
28-Feb-2025
, DOI: 10.37421/1948-593X.2025.17.476
Citation: © 2025 Dvorak T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Copyright: © 2025 Dvorak T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
High-throughput screening methods for antibiotic residue detection are designed to analyze hundreds to thousands of samples within a short time frame, with minimal sample preparation and operator intervention. These technologies combine advances in immunoassays, biosensors, microfluidics, and molecular biology to provide rapid and multiplexed analysis. Among the most widely used HTS techniques are Enzyme-Linked Immunosorbent Assays (ELISA), Lateral Flow Immunoassays (LFIA), and Fluorescence Polarization Immunoassays (FPIA), each offering specific advantages in terms of sensitivity, throughput, and field applicability. ELISA remains the gold standard for many screening programs, capable of detecting low nanogram-per-milliliter concentrations of antibiotics across a variety of matrices. Commercial ELISA kits are available for detecting β-lactams, tetracyclines, sulfonamides, and aminoglycosides, among others, and can be semi-automated for higher efficiency.
Advancements in biosensor technologies have also revolutionized HTS applications for antibiotic detection. Optical, electrochemical, and piezoelectric biosensors integrated with microfluidic chips allow real-time, label-free analysis of multiple antibiotic targets. These biosensors often utilize aptamers or monoclonal antibodies as biorecognition elements and can be scaled up for parallel sample testing. Surface Plasmon Resonance (SPR) biosensors and Electrochemical Impedance Spectroscopy (EIS)-based systems offer exceptional sensitivity and are being integrated into portable platforms for on-site testing in food processing environments. Furthermore, nanotechnology has enhanced signal amplification and detection limits in biosensors, using materials such as gold nanoparticles, carbon nanotubes, and quantum dots to improve assay performance.
Molecular-based HTS methods are also gaining prominence. Techniques such as real-time PCR and Loop-Mediated Isothermal Amplification (LAMP) can detect genes encoding antibiotic resistance or biosynthetic pathways, indirectly indicating the presence of antibiotic residues. More recently, CRISPR-Cas-based diagnostics have emerged as ultra-sensitive and highly specific tools for residue detection. These methods can be integrated with lateral flow devices or fluorescence readers to yield results in under an hour, offering both speed and accuracy. Additionally, mass spectrometry-based HTS platforms using Matrix-Assisted Laser Desorption Ionization (MALDI-TOF) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) with automated sample handling are being developed for semi-targeted and untargeted screening of antibiotics in complex food matrices [2].
Google Scholar Cross Ref Indexed at
Google Scholar Cross Ref Indexed at
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report